For one, they did not compare these children to children who had never been vaccinated, instead comparing them to those who had not been vaccinated in the past 30 days.   The bottom line is there was no control group.  A control group means the absence of the intervention being studied.  The intervention being studied in this case was vaccination.  It is unscientific and wrong to assume that the less recently vaccinated are not having seizures.  In fact, part of the problem is that seizures are often ongoing, even life-long.

 

They found in this study that DPT and MMR increase the risk of seizures.  They did not find, nor would that have found, that those seizures immediately stopped after 30 days.  Given that seizures are recurring , it is meaningless to compare to the less recently vaccinated. OF COURSE there are no differences between the groups. They have all been vaccinated, all groups in this study would be expected to include children having seizures. There is, in fact, no reason to expect the recently vaccinated to be having more seizures than the less recently vaccinated over time.

 

And what do they mean when they say the study was” based on 679,942 youngster”?  

 

Why were only “febrile seizures” followed?  Etc., etc.

 

And maybe seizures are not necessary for long-term neurological problems to occur, hence another reason for the apparent lack of difference.

 

Also please note that they said “There are significantly elevated risks of febrile seizures after receipt of DTP vaccine or MMR vaccine, but these risks do not appear to be associated with any long-term, adverse consequences “, and that appearances can be deceiving… - SM

 

http://content.nejm.org/cgi/content/abstract/345/9/656

 

 

The Risk of Seizures after Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine

William E. Barlow, Ph.D., Robert L. Davis, M.D., M.P.H., John W. Glasser, Ph.D., M.P.H., Phillip H. Rhodes, Ph.D., Robert S. Thompson, M.D., John P. Mullooly, Ph.D., Steven B. Black, M.D., Henry R. Shinefield, M.D., Joel I. Ward, M.D., S. Michael Marcy, M.D., Frank DeStefano, M.D., Virginia Immanuel, M.P.H., John A. Pearson, M.D., Constance M. Vadheim, Ph.D., Viviana Rebolledo, B.S., Dimitri Christakis, M.D., M.P.H., Patti J. Benson, M.P.H., Ned Lewis, M.P.H., Robert T. Chen, M.D., for the Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group

Table of Contents Full Text of this article PDF of this article Editors' Summaries Find Similar Articles in the Journal Weekly Briefings Summary Add to Personal Archive Download to Citation Manager Alert me when this article is cited Articles in Medline by Author: Barlow, W. E. Vaccines

ABSTRACT

Background The administration of the diphtheria and tetanus toxoids and whole-cell pertussis (DTP) vaccine and measles, mumps, and rubella (MMR) vaccine has been associated with seizures. We studied the relation between these vaccinations and the risk of a first seizure, subsequent seizures, and neurodevelopmental disability in children.

Methods This cohort study was conducted at four large health maintenance organizations and included reviews of the medical records of children with seizures. We calculated the relative risks of febrile and nonfebrile seizures among 679,942 children after 340,386 vaccinations with DTP vaccine, 137,457 vaccinations with MMR vaccine, or no recent vaccination. Children who had febrile seizures after vaccination were followed to identify the risk of subsequent seizures and other neurologic disabilities.

Results Receipt of DTP vaccine was associated with an increased risk of febrile seizures only on the day of vaccination (adjusted relative risk, 5.70; 95 percent confidence interval, 1.98 to 16.42). Receipt of MMR vaccine was associated with an increased risk of febrile seizures 8 to 14 days after vaccination (relative risk, 2.83; 95 percent confidence interval, 1.44 to 5.55). Neither vaccination was associated with an increased risk of nonfebrile seizures. The number of febrile seizures attributable to the administration of DTP and MMR vaccines was estimated to be 6 to 9 and 25 to 34 per 100,000 children, respectively. As compared with other children with febrile seizures that were not associated with vaccination, the children who had febrile seizures after vaccination were not found to be at higher risk for subsequent seizures or neurodevelopmental disabilities.

Conclusions There are significantly elevated risks of febrile seizures after receipt of DTP vaccine or MMR vaccine, but these risks do not appear to be associated with any long-term, adverse consequences.

Source Information

From the Immunization Studies Program, Center for Health Studies, Group Health Cooperative, Seattle (W.E.B., R.L.D., R.S.T.); the Department of Biostatistics, University of Washington, Seattle (W.E.B.); the National Immunization Program, Vaccine Safety and Development Activity, Centers for Disease Control and Prevention, Atlanta (J.W.G., P.H.R., F.D., R.T.C.); the Center for Health Research, Northwest Kaiser Permanente, Portland, Oreg. (J.P.M.); the Division of Research, Kaiser Permanente of Northern California, Oakland (S.B.B., H.R.S.); the UCLA Center for Vaccine Research, Harbor–UCLA Medical Center, Torrance, Calif. (J.I.W.); and the Kaiser–UCLA Vaccine Research Group, Southern California Kaiser Permanente, Panorama City, Calif. (S.M.M.).

Other authors were Virginia Immanuel, M.P.H. (Immunization Studies Program, Center for Health Studies, Group Health Cooperative, Seattle), John A. Pearson, M.D. (Center for Health Research, Northwest Kaiser Permanente, Portland, Oreg.), Constance M. Vadheim, Ph.D. (UCLA Center for Vaccine Research, Harbor–UCLA Medical Center, Torrance, Calif.), Viviana Rebolledo, B.S. (Immunization Studies Program, Center for Health Studies, Group Health Cooperative, Seattle), Dimitri Christakis, M.D., M.P.H. (Department of Pediatrics, University of Washington, Seattle), Patti J. Benson, M.P.H. (Immunization Studies Program, Center for Health Studies, Group Health Cooperative, Seattle), and Ned Lewis, M.P.H. (Division of Research, Kaiser Permanente of Northern California, Oakland).

Address reprint requests to Dr. Davis at the Center for Health Studies, Group Health Cooperative, 1730 Minor Ave., Suite 1600, Seattle, WA 98101-1448.

Sign in for Full Text

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.